Clinical trials
Phase 3 Crohn Disease trials in Greece
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2011 | 1 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 6 |
| 2018 | 7 |
| 2019 | 2 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Terminated | 9 |
| Recruiting | 7 |
| Active, not recruiting | 4 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 8 |
| Celgene | 6 |
| Shire | 3 |
| Takeda | 3 |
| Lakefront Biotherapeutics NV | 2 |
| Abbott | 1 |
| Boehringer Ingelheim | 1 |
| Celltrion | 1 |
| Centocor Ortho Biotech Services, L.L.C. | 1 |
| Eli Lilly and Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Crohn Disease | 32 |
| Colitis, Ulcerative | 2 |
| Gastroenteritis | 1 |
| Irritable Bowel Syndrome | 1 |
| Obesity | 1 |
| Overweight | 1 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.